Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Davita Inc

Article Abstract:

DaVita Inc.'s earnings should advance in 2003 and 2004 by 5% to 20-25% respectively. The company has a strong cash flow and repayment of debt is not yet due till 2006 but safety rank is below average and earnings predicatability only 5%, stock is suitbale for for risk-tolerant investorr.

Author: Chow, Nancy
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Evaluation, Rankings

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

US Oncology

Article Abstract:

US Oncology which has invested in cancer care centers is expected to advance 15%-20% in share earnings by 2003 and 2004. Shares are ranked to outperform t he market .

Author: Chow, Nancy
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
US Oncology Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Davita Inc

Article Abstract:

DaVita Inc. expects to have its earnings advance in 2003 and 2004. Shares are timely with above average appreciation potential out to 2006-2008.

Author: Chow, Nancy
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Finance, Health care industry, Company investment, Investments, Statistics, Securities, Company sales and earnings, Company earnings/profit, Company securities, Company business forecast/projection, Company forecasts, DaVita Inc.
Similar abstracts:
  • Abstracts: Harmonic, Inc. Oak Technology. Shaw Comm. 'B.'
  • Abstracts: Aviall Inc. Danaher Corp. Humana Inc
  • Abstracts: DRS Technologies Inc. Esco Technologies Inc
  • Abstracts: Fifth Third Bancorp. U.S. Bancorp
  • Abstracts: Capitol Federal Financial. TFC Financial Corp
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.